Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
- PMID: 20658644
- DOI: 10.1002/em.20568
Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
Abstract
FANCJ (also known as BRIP1 or BACH1) is a DNA helicase that was originally identified by its direct interaction with the hereditary breast cancer protein, BRCA1. Similar to BRCA1, FANCJ function is essential for DNA repair and breast cancer suppression. FANCJ is also mutated in the cancer prone syndrome Fanconi anemia, for which patient cells are characterized by extreme sensitivity to agents that generate DNA interstand crosslinks. Unexpectedly, correction of the interstrand crosslink sensitivity of FANCJ-null patient cells did not require the FANCJ/BRCA1 interaction. Instead, FANCJ binding to the mismatch repair protein, MLH1 was required. Given this finding, we address the role of FANCJ and MLH1 in DNA crosslink processing and how their functions could be linked in checkpoint and/or recombination pathways. We speculate that after DNA crosslink processing and repair, the FANCJ/MLH1 interaction is critical for recovery and restart of replication. These ideas are considered and summarized in this review.
Environ. Mol. Mutagen., 2010. (c) 2010 Wiley-Liss, Inc.
Similar articles
-
The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells.EMBO J. 2007 Jul 11;26(13):3238-49. doi: 10.1038/sj.emboj.7601754. Epub 2007 Jun 21. EMBO J. 2007. PMID: 17581638 Free PMC article.
-
Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses.EMBO J. 2014 Aug 1;33(15):1698-712. doi: 10.15252/embj.201387530. Epub 2014 Jun 25. EMBO J. 2014. PMID: 24966277 Free PMC article.
-
Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.Future Oncol. 2011 Feb;7(2):253-61. doi: 10.2217/fon.10.191. Future Oncol. 2011. PMID: 21345144 Free PMC article. Review.
-
An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy.Cancer Prev Res (Phila). 2010 Nov;3(11):1409-16. doi: 10.1158/1940-6207.CAPR-10-0118. Epub 2010 Oct 26. Cancer Prev Res (Phila). 2010. PMID: 20978114 Free PMC article.
-
FANCJ at the FORK.Mutat Res. 2016 Jun;788:7-11. doi: 10.1016/j.mrfmmm.2016.02.003. Epub 2016 Feb 17. Mutat Res. 2016. PMID: 26926912 Free PMC article. Review. No abstract available.
Cited by
-
Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden.Mol Metab. 2024 Nov;89:102035. doi: 10.1016/j.molmet.2024.102035. Epub 2024 Sep 18. Mol Metab. 2024. PMID: 39304062 Free PMC article.
-
Helicase-inactivating mutations as a basis for dominant negative phenotypes.Cell Cycle. 2010 Oct 15;9(20):4080-90. doi: 10.4161/cc.9.20.13667. Cell Cycle. 2010. PMID: 20980836 Free PMC article. Review.
-
What is wrong with Fanconi anemia cells?Cell Cycle. 2014;13(24):3823-7. doi: 10.4161/15384101.2014.980633. Cell Cycle. 2014. PMID: 25486020 Free PMC article. Review.
-
Tissue-Specific Effects of the DNA Helicase FANCJ/BRIP1/BACH1 on Repeat Expansion in a Mouse Model of the Fragile X-Related Disorders.Int J Mol Sci. 2025 Mar 15;26(6):2655. doi: 10.3390/ijms26062655. Int J Mol Sci. 2025. PMID: 40141297 Free PMC article.
-
The DNA helicase FANCJ (BRIP1) functions in double strand break repair processing, but not crossover formation during prophase I of meiosis in male mice.PLoS Genet. 2024 Feb 20;20(2):e1011175. doi: 10.1371/journal.pgen.1011175. eCollection 2024 Feb. PLoS Genet. 2024. PMID: 38377115 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous